Skip to content

Evidence Hub

Blog
May 6, 2024

Navigating the European Union's Medical Device Regulation (MDR)

On May 26, 2021 the European Union’s (EU) Medical Device Regulation (MDR) became ...
Start Reading
On-Demand Webinar
Apr 22, 2024

Synthetic Data Webinar | May 15, 2024

Watch twebinar The Replicability of Analysis Results Using Synthetic Clinical Trial Data ...
Start Reading
Blog
Apr 20, 2024

How to unleash the replicability potential of synthetic data

In today's data-driven world, the need for innovative solutions to evolve alongside the ...
Start Reading
Case Study
Apr 19, 2024

Case Study: Enhancing clinical trial data sharing with synthetic datasets

Unlock the future of research with our groundbreaking approach to privacy-preserving data ...
Start Reading
Case Study
Apr 19, 2024

Case Study. Data Guardian: Securing Enterprise Health Data through an Advanced Risk Assessment and De-Identification Solution

Our case study explores how our client, a leading American retail company, and its ...
Start Reading
Case Study
Apr 19, 2024

Case Study: Unlock the Replicability Power of Synthetic Data in Health Research – with Practical and Reliable Guidelines

Embark on a journey to harness the full potential of Synthetic Data Generation (SDG) ...
Start Reading
Whitepaper
Apr 19, 2024

Whitepaper: RWE as Confirmatory Evidence for Accelerated Approvals

Since 1992, the FDA has paved the way for life-saving medicines to reach patients swiftly ...
Start Reading
Blog
Apr 3, 2024

Key Takeaways from the public workshop, “Advancing Real-World Data to Generate Regulatory Grade Real-World Evidence in Oncology”

By Inish O’Doherty and Purva Jain
Start Reading
Publication
Mar 24, 2024

An evaluation of the replicability of analyses using synthetic health data

This paper published in Scientific Reports describes a study evaluating the replicability ...
Start Reading
Blog
Mar 21, 2024

FDA releases draft guidance on non-interventional studies for drug and biological products

The Food and Drug Administration (FDA) continues to advance its RWE Program, this time ...
Start Reading
Presentation
Dec 13, 2023

Ten Things I have Learned About Synthetic Data Generation

Khaled El Emam, SVP & GM, Replica Analytics
Start Reading
Blog
Dec 7, 2023

Aetion’s comments to FDA on recent draft guidance on the substantial evidence standard

This week, Aetion submitted a letter to FDA commenting on the Agency’s recent draft ...
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 2: Perspectives from Health Regulators

Title: High-Fidelity Synthetic Data Applications for Data Augmentation
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 5: Applications in Complex Healthcare Settings

Title: Generating Synthetic Data for the NHS
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 4: Applications of Synthetic Data in the Life Sciences Industry II

Title: Applications of Privacy Enhancing Technology to Data Sharing at a Global ...
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 3: Applications of Synthetic Data in the Life Sciences Industry I

Title: Applications of Synthetic Data in Supporting Data Products and Analytics for Real ...
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Welcome / Opening remarks

Speaker: Khaled El Emam GM and SVP, Replica Analytics; Professor, University of Ottawa
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 1: Regulating Privacy Risks from Synthetic Data

Title: Assessing the Privacy Risks of Synthetic Data and Other PETs
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Session 6: New Applications

Title: Assessing Utility and Building Industry Trust for Imaging Data in Healthcare
Start Reading
Presentation
Nov 30, 2023

Synthetic Data Summit 2023 | Closing Remarks

Speaker: Dorothee Bartels Chief Digital Officer, Aetion
Start Reading
Blog
Nov 29, 2023

Research Spotlight: A Deep Dive into a Real-World Reproducibility Study

Both real-world data (RWD) and real-world evidence (RWE) studies continue to effectively ...
Start Reading
Blog
Nov 16, 2023

Partnering to enhance Japanese RWD at a global scale: A Q&A with JMDC

JMDC, a leading Japanese health big data firm, and Aetion® recently announced a ...
Start Reading
Blog
Nov 8, 2023

Research Spotlight: Navigating Treatment Effectiveness in Rare Oncology with External Control Cohorts

Real-world data (RWD) has proven to be a pivotal tool in understanding patient treatment ...
Start Reading
Publication
Nov 1, 2023

Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets

This paper published in the Journal of Clinical Oncology: Clinical Cancer Informatics ...
Start Reading